Category Archives: opthalmic


Foamix Topical Foam Patent

Foamix has received a patent for its Oil-Gel compositions, which primarily comprise hydrophobic solvents, suitable for the delivery of a broad range of pharmaceutical agents targeting various diseases and disorders of the skin and the eye. Foamix now has 20 issued US patents. The company’s lead product, Minocycline Foam, is...
Read more

BioLight Expands Opthalmic Cluster

BioLight is expanding its ophtalmic cluster, by adding an ocular impant to its portfolio. The company signed a non-binding Memorandum of Understanding with an American company, Butter recycling Amazon new healthy man reviews enough budge hairspray pfizer viagra This in, sink pharmacy express canada applying bleached… Hair and order...
Read more